Insider · CIK 0001770790

Lamond David

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001770790

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	IRLAIRulya Therapeutics Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+2,700 sh	—	—	2,700
2026-01-02	IRLAIRulya Therapeutics Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+29.4K sh	—	—	29,423
2025-06-04	IRLAIRulya Therapeutics Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2025-01-02	IRLAIRulya Therapeutics Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+47.6K sh	—	—	47,587
2024-06-05	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+27K sh	—	—	27,000
2023-12-14	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+22.6K sh	$1.04	+$23.5K	2,347,545
2023-12-13	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+22.6K sh	$1.00	+$22.6K	2,324,918
2023-12-12	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+300 sh	$1.00	+$300	2,279,964
2023-12-12	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+22.3K sh	$1.02	+$22.8K	2,302,291
2023-12-07	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+19.1K sh	$1.01	+$19.3K	2,279,664
2023-12-06	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+19.1K sh	$1.02	+$19.5K	2,260,541
2023-12-05	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+19.1K sh	$1.01	+$19.3K	2,241,418
2023-12-01	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+14.4K sh	$0.94	+$13.5K	2,222,295
2023-11-30	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+14.4K sh	$0.90	+$12.9K	2,207,917
2023-11-29	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+14.4K sh	$0.98	+$14.1K	2,193,539
2023-08-31	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+41K sh	$1.32	+$54.2K	2,179,161
2023-08-30	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+41K sh	$1.31	+$53.7K	2,138,135
2023-08-17	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+24.8K sh	$1.29	+$31.9K	2,097,109
2023-08-16	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+117K sh	$1.29	+$151K	2,072,343
2023-08-15	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+108K sh	$1.32	+$142K	1,954,995
2023-05-24	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+27K sh	—	—	27,000
2022-06-08	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+27K sh	—	—	27,000
2022-06-01	Lucira Health, Inc.Stock Option (right to buy)A Award	Director	AAward	+59.5K sh	—	—	59,459
2022-05-24	Applied Molecular Transport Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-05-23	Applied Molecular Transport Inc.P Purchase	Director	PPurchase	+33.5K sh	$3.26	+$109K	1,077,519
2022-05-20	Applied Molecular Transport Inc.P Purchase	Director	PPurchase	+33K sh	$3.08	+$102K	1,044,019
2022-05-19	IRLAIRulya Therapeutics Inc.A Award	Director	AAward	+200K sh	—	—	1,734,722
2021-06-16	IRLAIRulya Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,029
2021-05-18	Applied Molecular Transport Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.2K sh	—	—	15,175
2021-04-06	Applied Molecular Transport Inc.P Purchase	Director	PPurchase	+25K sh	$42.00	+$1.05M	1,011,019
2021-03-24	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+50K sh	$33.77	+$1.69M	1,847,109
2021-03-04	IRLAIRulya Therapeutics Inc.G Gift	Director	GGift	+1.53M sh	—	—	1,534,720
2021-03-04	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+16.6K sh	$34.28	+$570K	1,763,730
2021-03-04	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+13.3K sh	$35.00	+$466K	1,777,040
2021-03-04	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+16K sh	$36.34	+$580K	1,793,009
2021-03-04	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+4,100 sh	$36.86	+$151K	1,797,109
2021-02-09	Lucira Health, Inc.C Conversion	Director	CConversion	+53.6K sh	—	—	53,629
2021-02-09	Lucira Health, Inc.C Conversion	Director	CConversion	+92.8K sh	—	—	146,385
2021-02-09	Lucira Health, Inc.Series B Preferred StockC Conversion	Director	CConversion	−53.6K sh	—	—	0
2021-02-09	Lucira Health, Inc.Series C Preferred StockC Conversion	Director	CConversion	−92.8K sh	—	—	0
2020-06-09	Applied Molecular Transport Inc.C Conversion	Director	CConversion	+915K sh	—	—	914,589
2020-06-09	Applied Molecular Transport Inc.A Award	Director	AAward	+71.4K sh	$14.00	+$1M	986,019
2020-06-09	Applied Molecular Transport Inc.Series A Preferred StockC Conversion	Director	CConversion	−1 sh	—	—	0
2020-06-09	Applied Molecular Transport Inc.Series B Preferred StockC Conversion	Director	CConversion	−1 sh	—	—	0
2020-06-09	Applied Molecular Transport Inc.Series C Preferred StockC Conversion	Director	CConversion	−1 sh	—	—	0
2020-06-08	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,029
2020-06-04	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+13.6K sh	$42.13	+$573K	1,711,593
2020-06-04	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+10.6K sh	$43.32	+$461K	1,722,235
2020-06-04	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+24.9K sh	$43.88	+$1.09M	1,747,109
2020-05-19	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+400 sh	$54.09	+$21.6K	1,659,184

Recent filings

Accepted (ET)
Jun 154
Lamond David0000912282-26-000832
SEC(opens sec.gov)
Jan 214
Lamond David0000912282-26-000085
SEC(opens sec.gov)
Jun 64
Lamond David0000912282-25-000619
SEC(opens sec.gov)
Jan 84
Lamond David0001415889-25-001162
SEC(opens sec.gov)
Jun 74
Lamond David0001415889-24-016093
SEC(opens sec.gov)
Dec 144
Lamond David0001209191-23-058694
SEC(opens sec.gov)
Dec 74
Lamond David0001209191-23-057799
SEC(opens sec.gov)
Dec 14
Lamond David0001209191-23-057053
SEC(opens sec.gov)
Aug 314
Lamond David0001209191-23-047880
SEC(opens sec.gov)
Aug 174
Lamond David0001209191-23-046402
SEC(opens sec.gov)

Companies

Address

C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 273

SOUTH SAN FRANCISCO, CA, 94080